Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$400M |
| 2 |
Citigroup
C
|
+$395M |
| 3 |
CELG
Celgene Corp
CELG
|
+$360M |
| 4 |
Amazon
AMZN
|
+$347M |
| 5 |
RTX Corp
RTX
|
+$344M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$397M |
| 2 |
Salesforce
CRM
|
+$355M |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$354M |
| 4 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$349M |
| 5 |
Autodesk
ADSK
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.37% |
| 2 | Financials | 4.87% |
| 3 | Healthcare | 3.8% |
| 4 | Consumer Discretionary | 3.79% |
| 5 | Industrials | 3.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
CarMax
KMX
$8.52B
| $43M | 0.02% |
494,847
+46,437
| +10% | +$3.63M |
|
|
UFS
802
DELISTED
DOMTAR CORPORATION (New)
UFS
| $42.9M | 0.02% |
963,624
-378,598
| -28% | -$17.3M |
|
803
CALL
Kraft Heinz
KHC
$30.1B
| $42.8M | 0.02% |
1,379,500
+405,800
| +42% | +$12.8M |
|
804
CALL
Boston Scientific
BSX
$74.9B
| $42.8M | 0.02% |
996,100
+668,900
| +204% | +$25.7M |
|
805
CALL
CME Group
CME
$96.1B
| $42.8M | 0.02% |
220,400
+23,100
| +12% | +$4.26M |
|
|
VNE
806
DELISTED
Veoneer, Inc.
VNE
| $42.8M | 0.02% |
2,470,526
+1,719,151
| +229% | +$36M |
|
|
MOMO
807
PUT
Hello Group
MOMO
$850M
| $42.7M | 0.02% |
1,192,300
+298,200
| +33% | +$9.92M |
|
|
NVO
808
Novo Nordisk
NVO
$205B
| $42.7M | 0.02% |
1,672,492
+664,716
| +66% | +$16.4M |
|
809
PUT
Abbott
ABT
$193B
| $42.5M | 0.02% |
505,700
-149,900
| -23% | -$11.8M |
|
810
CALL
Expedia Group
EXPE
$39.4B
| $42.4M | 0.02% |
318,700
-129,100
| -29% | -$15.9M |
|
811
Middleby
MIDD
$5.29B
| $42.4M | 0.02% |
312,324
+179,326
| +135% | +$24.1M |
|
812
Merit Medical Systems
MMSI
$5.4B
| $42.4M | 0.02% |
711,164
+520,436
| +273% | +$29.8M |
|
813
CALL
Atlassian
TEAM
$42.1B
| $42.3M | 0.02% |
323,500
+117,600
| +57% | +$14.2M |
|
814
CALL
Honeywell
HON
$74.2B
| $42.2M | 0.02% |
256,656
+9,761
| +4% | +$1.55M |
|
815
Truist Financial
TFC
$64.7B
| $42.2M | 0.02% |
858,875
+528,524
| +160% | +$25.9M |
|
816
Ambev
ABEV
$43.8B
| $42.2M | 0.02% |
9,027,371
+4,235,529
| +88% | +$19M |
|
817
CALL
Marathon Petroleum
MPC
$100B
| $42.1M | 0.02% |
754,300
+141,800
| +23% | +$7.76M |
|
818
Wayfair
W
$13.9B
| $42.1M | 0.02% |
288,670
-168,072
| -37% | -$25.3M |
|
819
CALL
Allstate
ALL
$65.9B
| $42M | 0.02% |
413,200
+209,900
| +103% | +$20.5M |
|
820
Amgen
AMGN
$226B
| $41.9M | 0.02% |
227,456
+33,836
| +17% | +$6.06M |
|
821
CALL
Danaher
DHR
$143B
| $41.9M | 0.02% |
330,730
+151,265
| +84% | +$17.9M |
|
822
PUT
Accenture
ACN
$109B
| $41.8M | 0.02% |
226,200
-24,700
| -10% | -$4.44M |
|
823
PUT
Skyworks Solutions
SWKS
$10.5B
| $41.7M | 0.02% |
539,900
+4,700
| +0.9% | +$373K |
|
824
Workday
WDAY
$51B
| $41.7M | 0.02% |
202,766
-34,659
| -15% | -$7M |
|
825
CALL
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$142M
| $41.5M | 0.02% |
24,963
+5,813
| +30% | +$10.3M |
|
Similar funds
Ken Griffin's Q2 2019 Portfolio in Review
As of Q2 2019, Ken Griffin held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Griffin deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.
By sector, the portfolio is most concentrated in Technology at 5.4% of assets, down from 5.5% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.
- Ken Griffin's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
- Ken Griffin added most to Netflix in Q2 2019, an estimated $400M increase.
- Ken Griffin's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
- Ken Griffin fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
- Ken Griffin's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
- Ken Griffin opened 1,217 new positions and closed 1,335 in Q2 2019.
- Ken Griffin's portfolio value rose 8.5% quarter-over-quarter to $218B.
Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.